Literature DB >> 15885820

Behavioral assessment in mouse models of neuronal ceroid lipofuscinosis using a light-cued T-maze.

Kristy D Wendt1, Bo Lei, Todd R Schachtman, Gregory E Tullis, Margaret E Ibe, Martin L Katz.   

Abstract

Learning impairment is a common feature of the neuronal ceroid lipofuscinoses (NCL), a family of lysosomal storage disorders associated with progressive neurodegeneration. Murine models for the neuronal ceroid lipofuscinoses include the well-characterized motor neuron degeneration (mnd/mnd) model for one variant of late infantile NCL (CLN8), and the more recently generated models for the infantile (CLN1) and juvenile (CLN3) forms of NCL. To determine whether these mouse models exhibit behavioral deficits analogous to the learning impairment characteristic of the human disorders, the performance of these animals on an associative learning task was assessed. The abilities of affected and normal control mice to associate a light stimulus with a food reward were evaluated in 14-16-week-old animals using a T-maze. Normal mice were able to reach a criterion for having learned to make the association within a mean of 9.4 trials. The CLN8 and CLN3 mice, on the other hand, required means of 26.2 and 27.5 trials, respectively, to reach the same performance criterion (p<0.05), whereas none of the CLN1 mice were able to reach the criterion within a limit of 30 trials. The poor performance of the mutant mice did not appear to result from impaired retinal function; mice of all three strains exhibited retinal electrophysiological responses to dim light flashes and displayed robust pupillary light reflexes. Associative learning deficits appear to be an early disease phenotype in the NCL mouse models that will be useful for assessing the efficacy of therapeutic interventions such as gene or stem cell therapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885820     DOI: 10.1016/j.bbr.2005.02.024

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  9 in total

1.  Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorder.

Authors:  Rebecca C Ahrens-Nicklas; Luis Tecedor; Arron F Hall; Elena Lysenko; Akiva S Cohen; Beverly L Davidson; Eric D Marsh
Journal:  JCI Insight       Date:  2019-11-01

2.  Ocular phenotype in a mouse gene knockout model for infantile neuronal ceroid lipofuscinosis.

Authors:  Bo Lei; Gregory E Tullis; Mark D Kirk; Keqing Zhang; Martin L Katz
Journal:  J Neurosci Res       Date:  2006-10       Impact factor: 4.164

3.  Cln6 mutants associated with neuronal ceroid lipofuscinosis are degraded in a proteasome-dependent manner.

Authors:  Kristina Oresic; Britta Mueller; Domenico Tortorella
Journal:  Biosci Rep       Date:  2009-06       Impact factor: 3.840

Review 4.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

5.  Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Martin L Katz; Gary S Johnson; Gregory E Tullis; Bo Lei
Journal:  Neurobiol Dis       Date:  2007-09-07       Impact factor: 5.996

6.  Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Benedikt Grünewald; Maren D Lange; Christian Werner; Aet O'Leary; Andreas Weishaupt; Sandy Popp; David A Pearce; Heinz Wiendl; Andreas Reif; Hans C Pape; Klaus V Toyka; Claudia Sommer; Christian Geis
Journal:  Elife       Date:  2017-11-14       Impact factor: 8.140

7.  CRB2 Loss in Rod Photoreceptors Is Associated with Progressive Loss of Retinal Contrast Sensitivity.

Authors:  C Henrique Alves; Nanda Boon; Aat A Mulder; Abraham J Koster; Carolina R Jost; Jan Wijnholds
Journal:  Int J Mol Sci       Date:  2019-08-21       Impact factor: 5.923

8.  Gene expression profiling in a mouse model of infantile neuronal ceroid lipofuscinosis reveals upregulation of immediate early genes and mediators of the inflammatory response.

Authors:  Xingwen Qiao; Jui-Yun Lu; Sandra L Hofmann
Journal:  BMC Neurosci       Date:  2007-11-16       Impact factor: 3.288

9.  AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease.

Authors:  Tyler B Johnson; Katherine A White; Jon J Brudvig; Jacob T Cain; Logan Langin; Melissa A Pratt; Clarissa D Booth; Derek J Timm; Samantha S Davis; Brandon Meyerink; Shibi Likhite; Kathrin Meyer; Jill M Weimer
Journal:  Mol Ther       Date:  2020-09-24       Impact factor: 11.454

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.